Bone tissue diffusion of antibiotics;Diffusion osseuse des antibiotiques

Presse Medicale

Volumn 28, Issue 40, 1999, Pages 2265-2276

  Boselli, E ^a   Allaouchiche, B ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFAMANDOLE; CEFAZOLIN; CEFOTAXIME; CEFOTIAM; CEFRADINE; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CLOXACILLIN; FLUCLOXACILLIN; FOSFOMYCIN; IMIPENEM; ISOPENICILLIN N; LATAMOXEF; MACROLIDE; PEFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TIMENTIN; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC THERAPY; BONE BIOPSY; BONE INFECTION; DOSE CALCULATION; DRUG DIFFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFECTIOUS ARTHRITIS; MINIMUM INHIBITORY CONCENTRATION; ORTHOPEDIC SURGERY; REVIEW; TISSUE DISTRIBUTION;

ANTI-BACTERIAL AGENTS; BONE DISEASES; HUMANS; INFECTION; JOINT DISEASES;

EID: 0033582062     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Lopitaux R, Bussiere JL, Sirot J. Pénétration osseuse des antibiotiques. Rev Rhum 1978 ; 45:193-203.
2. Williams DN. Antibiotics penetration into bones and joints. Orthopaed Infect 1989 ; 6:53-9.
3. Saux MC Le Rebeller A, Leng B, Mintrosse J. Diffusion osseuse ce l'association sulfaméthoxazole-triméthoprime. Dosages effectués en chromatographie I quide à haute performance (CLHP). Pathol Biol 1982 ; 6:385-6.
4. Akimoto Y, Nishimura H, Komiya N et al. Ampicillin concentration in human serum, gingiva, the mandibular bone, and dental follicle following a single oral administration. Gen Pharmacol 1985 ; 16:125-8.
5. Akimoto Y, Kaneko K, Tamura T. Amoxicillin concentrations in serum, jaw cyst and jawbone following a single oral administration. J Oral Maxiofacial Surg 1982 ; 40:287-93.
6. Wildfeuer A, Mallwitz J, Gotthardt et al. Pharmakokine tics of ampicillin, sulbactam and cefotiam in patients undergoing orthopedic surgery. Infection 1997 ; 25:258-62.
7. Pignalelli M, Santoro F, Fraschini F, Scaglione F. Concentration of antibiotics in various jaw tissues : concentration of amoxicillin. Dent Cadmos 1981 ; 49:17-22.
8. Grimer RJ, Karpinski MR, Andrews JM, Wise R. Pene tration of amoxicillin and clavulanic acid into bone. Chemotherapy 1986 ; 32:185-91.
9. Weismeier K, Adam D, Heilmann HD, Koeppe P. Penetration of amoxicillin/clavulanate into human bone. J Antimicrob Chemother 1989 ; 24:93-100.
10. Unsworth PF, Heatlew FW, Phillips I. Fludoxacillin in bone. J Clin Pathol 1978 ; 31:705-11.
11. Holm S, Larsson SE. The penetration of flucloxacillin into cortical anc cancellous bone during arthroplasty of the knee. Int Orthop 1982 ; 6:243-7.
12. Sirot J, Lopitaux R, Dumont C, Delisle JJ, Rampon S, Cluzel R. Diffusion de la cloxacilline dans le tissu osseux humain après administration par voie orale. Pathol Biol 1982 ; 30:332-5.
13. Adam D, Heilmann HD, Weismeier K. Concentration of ticarcillin and clavulanic acid in human bone after prophylactic administration of 5.2 g of Timentin. Antimicrob Agents Chemother 1987 ; 31:935-9.
14. Incavo SJ, Ronchetti PJ, Choi JH, Wu H, Kinzing M, Sörgel F. Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues. Antimicrob Agents Chemother 1994 ; 38:905-7.
15. Acar JF, Kitzis MD, Evrard J, Mazas F. Pénétration osseuse de la céfazoline. Pothol Biol 1982 ; 10:33-6.
16. Polk R, Hume A, Kline BJ, Cardea J. Penetration of moxalactam and cefazolin into bone following simultaneous bolus or infusion. Clin Orthop 1983 ; 177:216-21.
17. Cunha BA, Cossling HR, Pasternak HS, Nightingale CH, Quintilani R. Penetration of cephalosporins into bone. Infection 1984 ; 12:80-4.
18. Friedman RJ, Friedrich LV, White RL, Kays MB, Brundage DM, Graham J. Antibiotic prophylaxis and tourniquet inflation in total knee arthroplasty. Clin Orthop 1990 ; 260:17-23.
19. Middlehurst RJ, Pedlar J, Barker GR, Rood JP. Cephradine penetration of mandibular bone. J Oral Maxillofac Surg 1989 ; 47:672-3.
20. Middlehurst RJ, Rood JP. Cephradine penetration of mandibular bone. Int J Oral Maxillofac Surg 1990 ; 19:120-1.
21. Cain TJ, Jones JT, Woods P. Bone levels of cephradine and cefuroxime after intravenous administration in patients undergoing total hip replacement. Int Orthop 1987 ; 11:61-3.
22. Leigh DA, Marriner J, Nisbet D, Powell HDW, Church JCT, Wise K. Bone concentration of cefuroxime and cefamandole in the femoral head in 96 patients undergoing total hip replacement surgery. J Antimicrob Chemother 1982 ; 9:303-11.
23. Leigh DA. Serum and bone concentration of cefuroxime in patients undergoing knee arthroplasty. J Antimicrob Chemother 1986 ; 18:609-11.
24. Ketterl R, Wittwer W. Einsatzmöglichkeiten des Basiscephalosporins Cefuroxim in der Knochenchirurgie. Gewebespiegel, Wirksamkeit und Vertràglichkeit. Infection 1993 ; 21:21-7.
25. Alvarez Ferrero MM, Vree TB, Van Ewijk-Beneken Kolmer EWJ, Sloof TJJH. Relationship between plasma and bone concentrations of cefuroxime and fluclo-xacillin. Biopharm Drug Dispos 1994 ; 15:599-608.
26. Lovering AM, Perez J, Bowker KE, Reeves DS, Macgowan AP, Bannister G. A comparison of the penetration of cefuroxime and cephamandole into bone, fat and haematoma fluid in patients undergoing total hip replacement. J Antimicrob Chemother 1997 ; 40:99-104.
27. Williams DN. Gistilo RB, Beverley R, Kind AC. Bone and serum concentration of five cephalosporin drugs : relevance of prophylaxis and treatment in orthopaedic surgery. Clin Orthop 1983 ; 179:254-65.
28. Farinotti R, Vie P, Montes C, Cavagna R, Rosenbaum M, Duparc J. Etude de la diffusion osseuse du céfotiam chez l'homme. Pathol Biol 1989 ; 37:638-42.
29. Wittmann DH, Schassan HH, Kohler F, Seidel H. Zur Frage der Penetration von Moxalactam in den Knochen. Unfallchirurgie 1981 ; 7:142-6.
30. Wittmann DH, Schassand HH, Fraitag V. Pharmacokinetics studies and results of a clinical trial with cefotaxime (HR-756). In Nelson JD, Grassi C, eds : Current Chemotherapy and Infectious Deseases. Washington DC, American Society for Microbiology, 1980:114-16.
31. Braga PC, Pozzato C, Cedrini C et al. Clinical pharmacokinetics of cefotaxime and penetration in sputum, bone and prostatic tissue. Clin Ther 1982 ; 5:69-78.
32. Soudry B, Sirot J, Lopitaux R, Dumont C, Delisle JJ, Parenton M. Diffusion de la ceftriaxone dans le tissu osseux humain. Pathol Biol 1986 ; 34:859-62.
33. Wittman DH, Schassand HH, Kohler F, Seibert W. Pharmacokinetics studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid. J Antimicrob Chemother 1981 ; 8:293-7.
34. Leigh DA, Griggs J, Tighe CM et al. Pharmacokinetic study of ceftazidime in bone and serum in patients undergoing hip and knee arthroplasty. J Antimicrob Chemother 1985 ; 5:637-42.
35. Macgregor RR, Genty LO. Imipenem/cilastatin in the treatment of osteomyelitis. Am J Med 1985 ; 78:100-3.
36. Wittmann DH, Kuipers TH, Fock R, Höll M, Bauernfeind A. Knochenkonzentrationen von Imipenem nach Gabe von Imipenem/Cilastatin. Infection 1986 ; 14:S130-7.
37. Fleurette J, Renaud F, Flandrens JP. Diffusion de la gentamicine dans l'organisme. Gaz Med Fr 1974 ; 81:91-8.
38. Pechere JC, Blein B. La gentamicine dans le traitement de l'ostéomyélite chronique. Gaz Med Fr 1976 ; 81:105-12.
39. Smilak JD, Flittie WH. Bone concentrations of antimicrobial agents after patenteral administration. Antimicrob Agents Chemother 1976 ; 9:169-71.
40. Saux Mc, Grellet J, Castagnera L, Crockett R. Etude de la diffusion osseuse de l'association oxacilline-nétilmicine. J Pharm 1985 ; 4:497-510.
41. Mader JT, Landon GC, Calhoun J. Antimicrobial treatment of osteomyelitis. Clin Orthop 1993 ; 295:87-95.
42. Quentin C, Chevallereau B, Cantet P, Le Rebeller A, Bebear Cn. Pénétration osseuse de l'amikacine. Symposium Amiklin, Marrakech, 1985.
43. Sirot J, Hermet R, Lopitaux R. Concentration d'amikacine dans le tissu osseux et le tissu synovial. Symposium Amiklin, Marrakech, 1985.
44. Desbordes JM, Bouquet S, Breux JPh et al. Comparative penetration of 3 fuoroquinolones into human cranial bone tissue after administration of a single intravenous dox. Drugs 1993 ; 45:448-9.
45. Kapfer X, Hahn F, Dinkeldein U, Lucke C. Pharmacokinetics of intravenous ofloxacin in patients undergoing total hip endoprothesis. Drugs 1993 ; 45:450-1.
46. Meissner A, Borner K, Koeppe P. Concentration of ofloxacin in human bone and in cartilage. J Antimicrob Chemother 1990 ; 26:69-74.
47. Dellamonica P, Bernard E, Etesse H, Garaffo R, Drugeon HB. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine rases of chronic osteomyelitis. Eur J Clin Microbiol Infect Dis 1989 ; 8:1024-30.
48. Fong IW, Ledbetter WH, Vandenbroucke AC, Simbul M, Rahm V. Ciprofloxacin concentrations in bone and muscle after oral dosing. Antimicrob Agents Chemother 1986; 29:405-8.
49. Graziani AL, Lawson LA, Gibson GA, Steinberg MA, Macgregor RR. Vancomycin in infected and non infected human bore. Antimicrob Agents Chemother 1988 ; 32:1320-2.
50. Massias L, Dubois C, De Lentdecker P et al. Penetration of vancomycin in uninfected sternal bone. Antimicrob Agents Chemother 1992 : 36:2539-41.
51. Desplaces N, Mamoudy P. Ducroquet F, Larrouturou Ph, Kitzis MD. Vancomycine en perfusion continue et infections ostéo-articulaires à staphylocoques mutirésistants. Med Mal Infect 1997 ; 27:969-74.
52. Sirot J, Dumont C, Delisle JJ, Soudry B, Michel J. Pénétration de la teicoplanine dans l'os. Réunion interdisciplinaire de Chimiothérapie Anti-Infectieuse, 1986, Paris, Abst 221.
53. Rosina R, Avai A, Suter F et al. Pharmacokinetics of teicoplanin in human bone. 16th International Congress of Chemotherapy, 1989, Jerusalem, Abst 915.
54. Garcia-Zabarte A, Penalver D, Aguilera A, Trevino M, Couceiro J. Serum and bone levels of teicoplanin in total hip replacement. ICAAC, 1994, Abst 0445.
55. Thalhammer F, Nehrer S, Gradwohl I et al. Pharmacokinetics of teicoplanin in patients with hip replacement surgery. 7th European congress of clinical m crobiology and infectious diseases, 1995, Vienna, Abst 759.
56. Sorensen TS, Colding H, Schroeder E, Rosdahl VT. The penetration of cefazolin, erythromycin and methicillin into human bone tissue. Acta Orthop Scand 1978 ; 49:549-53.
57. Del Tacca M, Danesi R, Bernardini N et al. Roxithromycin penetration into gingiva and alveolar bone of odontoiatric patients. Chemotherapy 1990 ; 36:332-6.
58. Dornbusch K, Carlstrom A, Hugo H, Lindstrom A. Antibacterial activity of clindamycin and lincomycin in human bone. J Antimicrob Chemother 1977 ; 3:153-60.
59. Bystedt H, Dahlback A, Dornbusch K, Nord CE. Concentration of azidocillin, erythromycin, doxycycline plus clindamycin in human mandibular bone. Int J Oral Surg 1978; 7:442-9.
60. Sirot J, Prive L, Lopitaux R, Glanddier Y. Etude de la diffusion de la rifampicine dans le tissu osseux spongieux et compact au cours des prothèses totales de hanche. Pathol Biol 1983; 31:438-41.
61. Sirot J, Lopitaux R, Cluzel R, Delisle JJ, Sauvezie B. Dosage de la rifampicine dans l'os non infecté chez l'homme. Ann Inst Pasteur 1977 ; 128:229-36.
62. Sirot J, Lopitaux R, Dumont C, Rampon S, Cluzel R. Diffusion de la fosforrycine dans le tissu osseux chez l'homme. Pathol Biol 1983 ; 31:522-4.
63. Sirot J. Les infections bactériennes ostéo-articulaires en dehors des infections à mycobacténes - Les techniques bactériologiques au laboratoire. Med Mal Infect 1991 ; 21:470-5.
64. Goldstein F. Sensibilité et résistance des souches - Quotients inhibiteurs. In: Précis d'antibiothérapie pratique. Mainatdi JL ed. Phase 5 1995;81-147.
65. Grellet J, Saux MC. Pharmacocinétique des antibiotiques dans l'os et l'articulation. Limites de l'apport de cette information. Med Mal Infect 1992 ; spécial:792-7.